nd.gov - The Official Portal for North Dakota State Government North Dakota: Legendary. Follow the trail of legends
Go to the Health Department home page
Influenza-Associated Pediatric Mortality

2004 Case Definition

An influenza-associated death is defined for surveillance purposes as a death resulting from a clinically compatible illness that was confirmed to be influenza by an appropriate laboratory or rapid diagnostic test. There should be no period of complete recovery between the illness and death. Influenza-associated deaths in all persons aged <18 years should be reported.

A death should not be reported if:  

 
red bullet There is no laboratory confirmation of influenza virus infection.
red bullet The influenza illness is followed by full recovery to baseline health status prior to death.
red bullet The death occurs in a person 18 years or older.
red bullet After review and consultation there is an alternative agreed upon cause of death.
 
Laboratory criteria for diagnosis

Laboratory testing for influenza virus infection may be done on pre- or post-mortem clinical specimens, and include identification of influenza A or B virus infections by a positive result by at least one of the following:

 
red bullet Influenza virus isolation in tissue cell culture from respiratory specimens;
red bullet Reverse-transcriptase polymerase chain reaction (RT-PCR) testing of respiratory specimens;
red bullet Immunofluorescent antibody staining (direct or indirect) of respiratory specimens;
red bullet Rapid influenza diagnostic testing of respiratory specimens;
red bullet Immunohistochemical (IHC) staining for influenza viral antigens in respiratory tract tissue from autopsy specimens;
red bullet Four-fold rise in influenza hemagglutination inhibition (HI) antibody titer in paired acute and convalescent sera*.
 
Case classification

Confirmed - A death meeting the clinical case definition that is laboratory confirmed.

Laboratory or rapid diagnostic test confirmation is required as part of the case definition; therefore, all reported deaths will be classified as confirmed.

Comment

*Serologic testing for influenza is available in a limited number of laboratories, and should only be considered as evidence of recent infection if a four-fold rise in influenza (HI) antibody titer is demonstrated in paired sera. Single serum samples are not interpretable.

To Report an Influenza-Associated Pediatric Death, contact:

 

Michelle Feist
Influenza Surveillance Coordinator
North Dakota Department of Health
Phone: 800-472-2180 or 701-328-2378
or Tracy Miller, MPH
Influenza Program Manager
North Dakota Department of Health
Phone: 800-472-2180 or 701-328-2378